Rigel PharmaceuticalsvsThermo Fisher Scientific

RIGL and TMO stock compared: price, dividend, valuation and results, from SEC filings.

RIGL

Rigel Pharmaceuticals, Inc.

$44.46

Value $821M

RIGL's page

TMO

Thermo Fisher Scientific Inc

$700.22

Value $260B

TMO's page

Rigel Pharmaceuticals (RIGL) has a market value of $821M and Thermo Fisher Scientific (TMO) $260B. Over the last year, with dividends, RIGL moved +11.3% and TMO +19.5%. Dividend yield: RIGL none, TMO 0.26%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    RIGL$821M

    TMO$260B

    TMO is 317 times RIGL

  • Revenue, 12 months

    RIGL$288M

    TMO$47.4B

    TMO is 164 times RIGL

  • Net income, 12 months

    RIGL$307M

    TMO$7.1B

    TMO is 23 times RIGL

  • Operating margin

    RIGL26.3%

    TMO17.9%

    8.4 points apart

  • ROIC

    RIGL13.6%

    TMO8.2%

    5.4 points apart

  • P/E

    RIGL–

    TMO36.8

  • Dividend yield

    RIGL0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    RIGL+39.8%

    TMO+11.8%

    28.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

RIGL+39.8%

TMO+11.8%

5010015020222023202420252026
Returns by period
PeriodRIGLWith dividendsTMOWith dividends
1 year since November 12, 2025+11.3%Price +11.3%+19.5%Price +19.1%
3 years since November 13, 2023+455.7%+77.1% a yearPrice +455.8%+58.8%+16.7% a yearPrice +57.3%
5 years since November 12, 2021+39.8%+6.9% a yearPrice +39.8%+11.8%+2.3% a yearPrice +10.2%
10 years since November 15, 2016+54.4%+4.4% a yearPrice +54.4%+384.5%+17.1% a yearPrice +371.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

RIGLRigel PharmaceuticalsTMOThermo Fisher Scientific

Valuation

RIGLTMO
Valuation
Price$44.46$700.22
Market value$821M$260B
Enterprise value (EV)$782M$295B
P/E–36.8
P/E, 5-year median–32.7
P/B1.94.8
EV/EBIT10.334.9
Free cash flow yield–2.9%

Results and growth

RIGLTMO
Results and growth
Revenue, 12 months$288M$47.4B
Net income, 12 months$307M$7.1B
Free cash flow, 12 months–$7.6B
Earnings per share, 12 months$16.07$18.96
Revenue growth, year on year64.1%3.9%
Revenue growth a year, past+22.1%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

RIGLTMO
Margins and returns on capital
Gross margin89.6%–
Operating margin26.3%17.9%
Net margin106.6%14.9%
ROIC13.6%8.2%
ROE86.3%13.4%

Balance sheet

RIGLTMO
Balance sheet
Cash$99M$6.1B
Total debt$60M$41.4B
Net debt / EBITDA-0.53.7
Interest cover18.4×5.5×

Dividends and buybacks

RIGLTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: RIGL or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Rigel Pharmaceuticals or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($260B) is about 316.7 times Rigel Pharmaceuticals ($821M), at today's prices.

How did RIGL and TMO stock do over the last 10 years?

Since November 15, 2016, RIGL's price moved +54.4% and TMO's +371.0%. With dividends: RIGL +54.4% (+4.4% a year), TMO +384.5% (+17.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, RIGL or TMO?

The dividend yield at today's price is none for Rigel Pharmaceuticals and 0.26% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, Rigel Pharmaceuticals or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 106.6% for Rigel Pharmaceuticals and 14.9% for Thermo Fisher Scientific, and the operating margin 26.3% and 17.9%. Revenue was $288M and $47.4B.

Which is the better investment, Rigel Pharmaceuticals or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.